This inventor holds 13 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: Crititech, Inc.. Active years: 2017-2024.
Company Filing History:
Years Active: 2017-2024
Title: Innovations and Contributions of Joseph S. Farthing
Introduction
Joseph S. Farthing is a notable inventor based in Lawrence, Kansas, with a remarkable portfolio of 13 patents. His work primarily focuses on pharmaceutical innovations, particularly in the development of specialized particles for therapeutic applications.
Latest Patents
Among his latest patents is the invention related to Lapatinib particles and their uses. This patent discloses particles that consist of at least 95% by weight of lapatinib or a pharmaceutically acceptable salt thereof. These particles are characterized by a specific surface area (SSA) of at least 10 m/g and a mean particle size by volume distribution ranging from about 0.7 μm to about 8 μm. Another significant patent involves glucocorticoid 'nintedanib' particles and their therapeutic applications. This patent describes particles that also contain at least 95% by weight of a glucocorticoid, with a specific surface area of at least 10 m/g, along with methods for their production and use.
Career Highlights
Joseph S. Farthing is currently associated with Crititech, Inc., where he continues to innovate in the field of pharmaceuticals. His contributions have significantly advanced the understanding and application of drug delivery systems.
Collaborations
Throughout his career, Farthing has collaborated with notable colleagues, including Michael Baltezor and Mark D. Williams. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Joseph S. Farthing's contributions to pharmaceutical innovations through his patents and collaborations highlight his significant role in advancing therapeutic technologies. His work continues to impact the field positively.